How to use Technologies offered

A search for a cancer, preclinical stage, synthetic opportunity would use the selection "Therapeutics, Diagnostics" in 'Sector', 'Cancerous, neoplasmatic' in 'Disease Category', 'Drugs, Small Molecule' in 'Technology' and 'Preclinical' in 'Development Stage'.

Selection of 'Enabling Technology, Platform Technology' in 'Sector' will identify all kinds of research technologies that can be used in more areas of life sciences than pharmaceuticals only.

Each technology profile gives the name of a company or academic institute as source of the offer, and a link allowing to contact the potential licensor. In most cases a profile includes a pdf covering the available non-confidential information as well as detailed contact data.

Registered users can create non-public notifications profiles which will inform them about new 'Technologies Offered' entries fitting their needs as specified. In addition these profiles allow them to filter the available information more comfortably.


Platform performing in vivo drug screening for human genetic diseases to be adapted for new uses

Organization name

Enterprise Europe Network


A Spanish biotechnology company searches partners in order to adapt the platform they have developed for new uses. It is an automated biotechnological platform capable of performing massive in vivo drug screening using the fruit fly as a model for genetic diseases. It can be adapted to the new challenges of undefined target or target-based pesticide discovery.

The company would like to establish a technical cooperation in order to adapt the platform and test it for different applications.


A Spanish company that has as main goal the research and development of new types of therapeutic solutions for human disorders that currently lack effective treatments has developed a completely automated biotechnological platform capable of performing massive in vivo drug screening using the fruit fly (Drosophila melanogaster) as a model for human genetic diseases.

The platform has been used for the moment to provide the following services to industry and R&D groups:

  • Development of new Drosophila transgenic models for human diseases
  • Identification of therapeutic targets in pathologic pathways
  • Screening and/or drugs validation
  • Detection of potential antioxidants compounds
  • Discovery of novel pesticides

Currently the company is focused in finding a compound to treat the rare genetic pathology, Myotonic Dystrophy (DM1). The high-throughput screen (HTS) using DM1 transgenic flies of 8,000 compounds is completed. More than 30 compounds have passed this primary screening and they have been assessed by secondary tests to confirm their ability to reduce/abrogate DM1 phenotypes. They have initiated the preclinical development of two of those compounds.

While the technology platform is designed to enhance discovery of human pharmaceuticals, it can also be adapted with great efficiency to the new challenges of undefined target or targeted-based pesticide discovery.

The company is willing to receive proposals to adapt the platform system to different applications and develop new assessments methodologies.

Innovations and advantages of the offer

Drosophila have been extensively studied by researchers for decades, making them ideal models for disease research and the screening of potential therapies. Genetic techniques have introduced reliable diseaselike fly models.

Models developed from these simple invertebrate organisms allow us to rapidly obtain critical information about a molecule’s effectiveness, toxicity and target before costly and time-consuming clinical studies are even started.

Screening compounds in this manner (in vivo conditions) results in the identification of pharmacological features directly relevant for humans plus any potential effects on the whole organism can be assessed.

Current Stage of Development

Already on the market

Collaboration Type

  • Joint Venture Agreement
  • License Agreement
  • Financial Resources
  • Testing of new applications
  • Adaptation to specific needs


Type of partner sought: SME, industry, university, research centre

Specific area of activity of the partner: environment, medicine, health, research

Task to be performed: application of the platform into the required and defined use

Ref: 12 ES 23D1 3PB5

To view the contact information, attachments and url of this profile you have to login into your account or register a new account: Login Register

Your feedback

Please click here to log in to view the complete profile.


latest entries